Cassiello-Robbins Clair, Sauer-Zavala Shannon, Wilner Julianne G, Bentley Kate H, Conklin Laren R, Farchione Todd J, Barlow David H
Center for Anxiety and Related Disorders at Boston University, Boston University.
Depression Clinical and Research Program at Massachusetts General Hospital, Boston, MA.
J Nerv Ment Dis. 2018 Jul;206(7):549-554. doi: 10.1097/NMD.0000000000000834.
Dysregulated anger is often present in the emotional (i.e., anxiety, mood, and related) disorders; however, it is rarely targeted in treatment. Transdiagnostic treatments, which focus on processes that contribute to dysregulated emotions across the range of psychopathology, might represent an efficient way to treat this anger. Using a subset of data from a recently completed equivalency trial comparing the Unified Protocol for Transdiagnostic Treatment of Emotional Disorders (UP) to single diagnosis protocols (SDPs) for specific disorders, this study began exploring whether the UP led to great reductions in anger compared with the SDPs. Results indicated that there was a small, nonsignificant, decrease in anger in the UP condition, whereas there was a moderate, nonsignificant increase in anger in the SDP condition. At posttreatment, UP patients had significantly lower anger scores than patients who received an SDP. These preliminary results suggest that transdiagnostic treatments may be well poised to target dyregulated anger in the context of emotional disorders.
失调性愤怒在情感（即焦虑、情绪及相关）障碍中常常存在；然而，在治疗中它很少成为目标。跨诊断治疗专注于导致整个精神病理学范围内情绪失调的过程，可能是治疗这种愤怒的一种有效方法。本研究使用了最近完成的一项等效性试验中的部分数据，该试验将情感障碍跨诊断治疗统一方案（UP）与特定障碍的单一诊断方案（SDP）进行比较，开始探究与SDP相比，UP是否能更大程度地减少愤怒。结果表明，在UP组中愤怒有小幅但不显著的下降，而在SDP组中愤怒有中度但不显著的增加。在治疗后，UP组患者的愤怒得分显著低于接受SDP治疗的患者。这些初步结果表明，跨诊断治疗可能很适合在情感障碍背景下针对失调性愤怒。
